Biomarker panel may improve lung cancer risk assessment

August 6, 2018

(HealthDay)—Biomarker-based risk profiling has the potential to improve lung cancer risk assessment, according to a study published online July 12 in JAMA Oncology.

Florence Guida, Ph.D., from the International Agency for Research on Cancer in Lyon, France, and colleagues used samples from 108 ever-smoking patients with lung cancer diagnosed within a year of blood collection and samples from 216 smoking-matched controls to develop a lung cancer risk prediction model. The authors based the model on a panel of selected circulating protein biomarkers (cancer antigen 125 [CA125], carcinoembryonic antigen [CEA], cytokeratin-19 fragment [CYFRA 21-1], and the precursor form of surfactant protein B [Pro-SFTPB]) and compared its performance to a traditional risk prediction model and current U.S. screening criteria. The score was validated blindly using absolute risk estimates among 63 ever-smoking patients with lung cancer diagnosed within one year after blood collection and 90 matched controls from two large European population-based cohorts.

The researchers found that the integrated risk prediction model combining with the biomarker score yielded an area under the curve of 0.83 versus 0.73 for a model based on smoking exposure alone. With an overall specificity of 0.83, based on the U.S. Preventive Services Task Force screening criteria, the sensitivity of the integrated risk prediction (biomarker) model was 0.63 versus 0.43 for the smoking model. Conversely, with an overall sensitivity of 0.42, the integrated risk prediction model yielded a specificity of 0.95 compared with 0.86 for the smoking .

"This study provided a proof of principle in showing that a panel of circulating may improve lung risk assessment and may be used to define eligibility for computed tomography screening," the authors write.

The study was funded in part by 3M.

Explore further: Study shows biomarker panel boosts lung cancer risk assessment for smokers

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Study shows biomarker panel boosts lung cancer risk assessment for smokers

July 12, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history, capturing risk for people who have ever smoked, not only for heavy smokers, an international ...

Researchers identify the most accurate risk prediction models for selecting whom to screen for lung cancer

May 15, 2018
Four risk prediction models have been shown to be most accurate for selecting the highest risk ever-smokers for lung cancer screening. Researchers suggest that this data can be used to inform future lung cancer screening ...

Risk-based lung cancer screening may save more lives than current USPSTF guidelines

January 2, 2018
Lung cancer screening based on individual risk has the potential to save more lives than current recommendations by the U.S. Preventive Services Task Force (USPSTF). The findings are published in Annals of Internal Medicine.

Risk-based CT screening may reduce deaths from lung cancer

January 1, 2018
Compared to National Lung Screening Trial criteria, targeting screening those at highest risk from lung cancer mortality using a risk prediction tool may improve efficiency in terms of greater reduction in mortality from ...

Model more accurately predicts lung cancer risk

February 22, 2013
(HealthDay)—A new model to predict lung cancer risk is more accurate than previous criteria, according to a study published in the Feb. 21 issue of the New England Journal of Medicine.

Active surveillance of lung subsolid nodules reduces unnecessary surgery and overtreatment

July 17, 2018
Subsolid nodules (SSN) can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance. Conservative management of SSN will reduce unnecessary surgery and overtreatment in patients ...

Recommended for you

Rare cancer could be caught early using simple blood tests

August 14, 2018
A pioneering study into myeloma, a rare cancer, could lead to GPs using simple blood tests to improve early diagnosis.

First study on physical properties of giant cancer cells may inform new treatments

August 13, 2018
Polyploidal cancer cells—cells that have more than two copies of each chromosome—are much larger than most other cancer cells, are resistant to chemotherapy and radiation treatments and are associated with disease relapse. ...

Disrupted nitrogen metabolism might spell cancer

August 13, 2018
Nitrogen is a basic building block of all the body's proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in collaboration with colleagues from the National ...

'Undruggable' cancers slowed by targeting growth signals

August 13, 2018
As many as 50 percent of human cancer cases—across a wide variety of tissues—involve defects in a common cellular growth signaling pathway. These defects have so far defied most attempts to develop targeted therapies, ...

Breast cancers enlist the help of normal cells to help them spread and survive

August 13, 2018
Australian researchers have uncovered a secret communication hotline between breast cancers and the normal cells surrounding them. Importantly, the messages sent back and forth between the normal and tumor cells encourage ...

Drop the C-word to reduce anxiety and overtreatment, say experts

August 13, 2018
Medical researchers are calling for the word 'cancer' to be dropped from some doctor-patient conversations in a bid to reduce patient anxiety and harm from over treatment.The appeal in today's BMJ follows mounting evidence ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.